Literature DB >> 30288003

Malignant Spindle Cell Tumor Breast-a Diagnostic Dilemma.

Sheetal Arora1, Deepshikha Rana2, Mukta Pujani3, Varsha Chauhan3.   

Abstract

Primary malignant spindle cell tumors are rare constituting 1.0% of breast malignancies. Spindle cell lesions occurring in soft tissues can occur in breast with overlapping morphologies. It can present as benign lesion and have inconclusive cytological findings, so easily missed if not properly dealt with. Stromal sarcoma should be diagnosed only after thorough sectioning and negative staining for p63, broad spectrum, and high molecular weight keratin. We present a case of right breast lump. Cytological features revealed fibro histiocytic lesion. There were no areas of necrosis, hemorrhage, or calcification. Histopathologically, it showed partially encapsulated tumor with cells arranged in sheets, composed of oval to epithelioid cells with spindling at places with moderate pleomorphism (mitotic activity 6-7/10 hpf). Differential diagnosis of primary stromal sarcoma, metaplastic sarcoma, and phyllodes was made. Immunohistochemistry revealed vimentin positivity with focal positivity of S-100. Desmin, cytokeratin and smooth muscle actin, p63, ER, PR, and Her2-neu were negative. A final diagnosis of primary breast sarcoma of neural origin was established with the help of histopathology and immunohistochemistry. To conclude, it is of utmost importance to identify primary stromal sarcomas as they are known to spread very rapidly and have a poor prognosis.

Entities:  

Keywords:  Immunohistochemistry; Metaplastic carcinoma; Spindle cell sarcoma

Year:  2018        PMID: 30288003      PMCID: PMC6154355          DOI: 10.1007/s13193-018-0750-x

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  7 in total

Review 1.  Diagnosis and management of primary breast sarcoma.

Authors:  Sammy Al-Benna; Kerstin Poggemann; Hans-Ulrich Steinau; Lars Steinstraesser
Journal:  Breast Cancer Res Treat       Date:  2010-05-18       Impact factor: 4.872

Review 2.  Optimal management of sarcomas of the breast: an update.

Authors:  Eran Nizri; Ofer Merimsky; Guy Lahat
Journal:  Expert Rev Anticancer Ther       Date:  2014-03-10       Impact factor: 4.512

Review 3.  Spindle cell tumours of the breast: practical approach to diagnosis.

Authors:  A Al-Nafussi
Journal:  Histopathology       Date:  1999-07       Impact factor: 5.087

4.  Treatment for breast sarcoma: a large, single-centre series.

Authors:  T Pencavel; C P Allan; J M Thomas; A J Hayes
Journal:  Eur J Surg Oncol       Date:  2011-05-31       Impact factor: 4.424

5.  p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma.

Authors:  Meryem M Koker; Celina G Kleer
Journal:  Am J Surg Pathol       Date:  2004-11       Impact factor: 6.394

6.  Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases.

Authors:  Mark R Carter; Jason L Hornick; Susan Lester; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2006-03       Impact factor: 6.394

7.  Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network.

Authors:  Guilhem Bousquet; Cyril Confavreux; Nicolas Magné; Christine Tunon de Lara; Philip Poortmans; Elzbieta Senkus; Brigitte de Lafontan; Michel Bolla; Remy Largillier; Edouard Lagneau; Sidney Kadish; Claire Lemanski; Mahmut Ozsahin; Yazid Belkacémi
Journal:  Radiother Oncol       Date:  2007-11-26       Impact factor: 6.280

  7 in total
  1 in total

1.  Dermatofibrosarcoma protuberans - the use of neoadjuvant imatinib for treatment of an uncommon breast malignancy: a case report.

Authors:  Matthew W McGee; Sarag A Boukhar; Varun Monga; Ronald Weigel; Sneha D Phadke
Journal:  J Med Case Rep       Date:  2019-12-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.